IOL Chemicals posts robust Q3 & 9M FY26 results, PBT up 39% YoY
Chemicals delivered improved efficiency and optimal capacity utilization, with EBIT rising 37% YoY
Chemicals delivered improved efficiency and optimal capacity utilization, with EBIT rising 37% YoY
Garijo will be the first woman to lead Sanofi in its history
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
Revenue from operations rose to Rs. 23,637 million for the three months ended December 31, 2025
The company reported profit before tax of Rs.67 crore, up sharply from Rs.21 crore in the same period last year
Revenue from operations surged 30% year-on-year to Rs. 68,645 million
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
The board highlighted ongoing investments in Radiopharma, CDMO Sterile Injectables, and CRDMO businesses
HCG clinicians contributing to one of the largest bodies of oncology research from India
Subscribe To Our Newsletter & Stay Updated